Riskpilot← Back to searchSign inGet full accessRediviva Optik AB
ABActiveOrg 5565708350Drottninggatan 4Retail sale of medical and orthopaedic goods · NACE 4774Est. 19995-9 employees
Revenue 2025
SEK 7,8M
+10% vs 2024
EBITDA margin
18.5%
+53% vs 2024
Equity ratio
67.5%
Financial strength
Net profit 2025
SEK 1,1M
-31% vs 2024
| Revenue | SEK 7,8M | +10% |
| EBITDA | SEK 1,4M | +53% |
| Net profit | SEK 1,1M | -31% |
| Total assets | SEK 2,4M | -33% |
| Equity | SEK 1,6M | -34% |
| Employees | — | — |
Legal name
Rediviva Optik AB
Org number
5565708350
Legal form
Aktiebolag
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
28 maj 1999
Share capital
SEK 100 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva optisk detaljhandelsverksamhet, föreläsningar, optometrisk konsultverksamhet och därmed förenlig verksamhet.
Address
Drottninggatan 4
Phone
+4618103311
Email
info@rediviva.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5 734 | 7 394 | 7 634 | 7 096 | 7 819 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 626 | 1 198 | 1 093 | 945 | 1 444 |
| Depreciation & amort. | −11 | −11 | −0 | −0 | −6 |
| EBIT | 615 | 1 187 | 1 093 | 945 | 1 438 |
| Net financials | — | — | 9 | 41 | 14 |
| Profit before tax | 452 | 882 | 812 | 2 096 | 1 451 |
| Tax | −104 | −190 | −180 | −444 | −312 |
| Net profit | 348 | 692 | 632 | 1 652 | 1 139 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 868 | 3 584 | 3 756 | 3 647 | 2 439 |
| Equity | 1 132 | 1 424 | 1 355 | 2 508 | 1 647 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 220 | 1 340 | 1 289 | 1 139 | 792 |
| Total debt | 1 220 | 1 340 | 1 289 | 1 139 | 792 |
EBITDA margin
18.5%
This company
15.8%
Market median
+17% vs market
20212025
Equity ratio
67.5%
This company
38.2%
Market median
+77% vs market
20212025
Return on equity
69.2%
This company
18.4%
Market median
+276% vs market
20212025
Net profit margin
14.6%
This company
8.1%
Market median
+80% vs market
20212025
Asset turnover
3.21×
This company
1.12×
Market median
+187% vs market
20212025
Debt / equity
0.48×
This company
0.62×
Market median
+23% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AH | Audit | 2020 |
| Former (1) | ||
CM Audit | Audit | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Former (1) | ||
| Chairman | 2020 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Rediviva Optik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Hélène Maria Westberg | Audit | 0 companies |
| Carl-Erik Morin | Audit | 0 companies |
| Anki Dahlberg | Chairman | 0 companies |
| Helena Maria Eklöf | Deputy Board Member | 0 companies |
| Gudrun Kristina Marklund | Chairman | 0 companies |
| Carl Dawid Jonathan Stenlund | Board of Directors | 0 companies |